Internal Medicine Journal

publication venue for

Hospitalised exacerbations of chronic obstructive pulmonary disease: adherence to guideline recommendations in an Australian teaching hospital 2019
Integrating diabetic retinopathy screening within diabetes education services in Australia's diabetes and indigenous primary care clinics. 49:797-800. 2019
Association between Socio-Economic Status and Incident Atrial Fibrillation 2018
Clinical correlates of severe thrombocytopenia from temozolomide in glioblastoma patients. 48:1206-1214. 2018
Non Alcoholic Fatty Liver Disease Patients Attending Two Metropolitan Hospitals in Melbourne, Australia; High Risk Status and Low Prevalence. 48:1369-1376. 2018
Phosphate nephropathy: an avoidable complication of bowel preparation for colonoscopy. 48:1141-1144. 2018
Collecting patient-reported outcome measures. 47:1454-1457. 2017
Incidence, time of occurrence and response to heart failure therapy in patients with anthracycline cardiotoxicity. 47:104-109. 2017
Benefit from cytoreductive nephrectomy and the prognostic role of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma. 46:1291-1297. 2016
Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention. 46:559-565. 2016
Prescription opioid analgesics for pain management in Australia: 20years of dispensing. 46:955-963. 2016
ASSESSING THE QUALITY OF BACK PAIN REFERRALS TO AN AUSTRALIAN TERTIARY HOSPITAL: A RETROSPECTIVE OBSERVATIONAL STUDY. 45:22-22. 2015
NON-STRUCTURAL FACTORS ASSOCIATED WITH EXISTING AND NEW FOOT PAIN: DATA FROM THE TASMANIAN OLDER ADULT COHORT STUDY. 45:18-18. 2015
PREVALENCE AND PREDICTORS OF FOOT PAIN: RESULTS FROM AN AUSTRALIAN COHORT STUDY. 45:45-45. 2015
Checkpoint immunotherapy for cancer: Superior survival, unaccustomed toxicities. 45:696-701. 2015
Cost to government and society of chronic kidney disease stage 1–5: a national cohort study. 45:741-747. 2015
Growth and geographical variation in the use of cardiac imaging in Australia. 45:1115-1127. 2015
What is the evidence status of Appropriate Use Criteria (AUC)? Insight from a matching exercise with the guidelines for echocardiography. 45:864-869. 2015
The Australia and New Zealand Fontan Registry: description and initial results from the first population-based Fontan registry. 44:148-155. 2014
Chemotherapy-related cardiomyopathy: A neglected aspect of cancer survivorship. 44:939-950. 2014
Long-term tolerance and efficacy of adjunctive exenatide therapy on glycaemic control and bodyweight in type 2 diabetes: a retrospective study from a specialist diabetes outpatient clinic. 44:345-353. 2014
Outcomes of haematology/oncology patients admitted to intensive care unit at The Canberra Hospital. 44:1087-1094. 2014
Twenty-year trends in benzodiazepine dispensing in the Australian population. 44:57-64. 2014
General health of opioid substitution therapy clients. 43:1335-1338. 2013
Local perspective on a rare brain tumour: Adult medulloblastoma. 43:567-572. 2013
Recent trends in Victorian risk-adjusted in-hospital mortality: 1999-2009. 42:1218-1223. 2012
Body mass index, sexual difficulties and sexual satisfaction among people in regular heterosexual relationships: a population-based study. 42:641-651. 2012
Prevalence of risk factors for foot ulceration in patients with end-stage renal disease on haemodialysis. 42:e120-e128. 2012
Association between serum cystatin C, monocytes and other inflammatory markers. 42:517-522. 2012
Negotiating hope with chronic obstructive pulmonary disease patients: a qualitative study of patients and healthcare professionals. 42:816-822. 2012
Palliative care for patients with chronic obstructive pulmonary disease: exploring the landscape. 42:1053-1057. 2012
Symptomatic 5-fluorouracil-induced sinus bradycardia. 41:566-570. 2011
Tachycardia in adults with cystic fibrosis is associated with normal autonomic function. 41:455-461. 2011
Clinical effectiveness in everyday practice: improving outcomes for all patients through a national acute coronary syndrome data collaborative. 41:206-210. 2011
Anti-platelets in diabetes management. 40:458-462. 2010
Validity of the indicator ‘death in low-mortality diagnosis-related groups’ for measuring patient safety and healthcare quality in hospitals. 40:250-257. 2010
Prioritizing quality indicator development across the healthcare system: identifying what to measure. 39:648-654. 2009
The six-minute walk test: a useful metric for the cardiopulmonary patient. 39:495-501. 2009
Measuring the quality of hospital care: an inventory of indicators. 39:352-360. 2009
Validation of the hospital outcome prediction equation (HOPE) model for monitoring clinical performance. 39:283-289. 2009
Medullary carcinoma of the thyroid in a patient with colon cancer and a rising carcinoembryonic antigen level. 39:264-265. 2009
Validity of self-reported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: the AusDiab study. 39:49-53. 2009
Frequency of risk factors for foot ulceration in individuals with chronic kidney disease. 38:314-320. 2008
Prevalence of occult metastatic disease in patients undergoing18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules. 0:070521010100001-???. 2007
Diabetes: advances in treatment. 37:383-388. 2007
Engineering a safe landing: engaging medical practitioners in a systems approach to patient safety. 37:295-302. 2007
Readmission patterns in patients with chronic obstructive pulmonary disease, chronic heart failure and diabetes mellitus: an administrative dataset analysis. 35:296-299. 2005
Implementing evidence-based guidelines: inpatient management of chronic obstructive pulmonary disease. 35:151-155. 2005
Medical history from the viewpoint of the patient. 35:193-194. 2005
Clinical decision-making and myocardial viability: current perspectives. 35:118-125. 2005
Positron emission tomography scanning in the assessment of patients with lymphoma. 34:388-397. 2004
Rational care before rationed care. 33:210-210. 2003
Rational care before rationed care. 32:533-534. 2002
Feminism and medicine. 32:320-321. 2002
Hepatocellular carcinoma and chemoembolization. 31:517-522. 2001
Current status of positron emission tomography in oncology. 31:27-36. 2001
Australia needs an Ombudsman or Office for Research Integrity 2016
Author reply 2014
De novo activating epidermal growth factor mutations (EGFR ) in small-cell lung cancer 2017
P56: IMPLEMENTATION OF THE AUSPOLLEN PARTNERSHIP PROJECT AND PRE-EVALUATION SURVEY OF USER PERCEPTION OF THE VALUE OF LOCAL POLLEN INFORMATION 2017
P57: REVIEW OF EVIDENCE AND GAPS IN KNOWLEDGE ON THUNDERSTORM ASTHMA EPIDEMICS AND PUBLIC HEALTH IMPLICATIONS 2017
ASCIA-P30: THE AUSPOLLEN PARTNERSHIP: IMPLEMENTING A STANDARDISED NATIONAL POLLEN ALERT SYSTEM FOR BETTER MANAGEMENT OF ALLERGIC RESPIRATORY HEALTH 2016
Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers 2016
METASTATIC CLEAR CELL RENAL CELL CARCINOMA DEMONSTRATING FOCAL UPTAKE ON (68)GA-DOTATATE PET 2016
SEXTANT ANALYSIS OF [C-11] CHOLINE PET UPTAKES IN PROSTATE OF PATIENTS UNDERGOING NEOADJUVANT DOCETAXEL CHEMOTHERAPY: VALIDATION OF SUV, SUVR, K-I AND BPND IN ASSESSING TREATMENT RESPONSE 2016
DOSIMETRY OF I-124-PEG-AVP0458 DIABODY IN PATIENTS WITH TAG-72 POSITIVE OVARIAN OR PROSTATE CANCER 2015
ASCIA 2014 Poster Abstracts 2014
THE INFLUENCE OF EARLY LIFE TRAFFIC RELATED AIR POLLUTION EXPOSURE ON ASTHMA, ALLERGY AND SENSITISATION: A SYSTEMATIC REVIEW AND A META-ANALYSIS OF BIRTH COHORT STUDIES 2014
ARA Scientific Posters 2014
SITE SPECIFIC SULPHONATION OF TYROSINE INCREASES PEPTIDE HYDROPHILICITY AND FAVOURABLY ALTERS BIODISTRIBUTION: CYCLIC(RGDYK) AS A CASE STUDY 2014
FAT MASS AND DISABLING FOOT PAIN: A CROSS-SECTIONAL STUDY 2011
ARTERIAL FDG UPTAKE: WHAT IS NORMAL? 2019
IMPACT OF THE BONE SCAN IN A COMPLICATED MENINGOCOCCAL PATIENT 2019
"... THE HAND CARE COMPONENT WAS ALMOST SECONDARY". THE ROLE OF HOSPITAL SYSTEMS IN ENABLING NURSES WITH SUSPECTED OCCUPATIONAL CONTACT DERMATITIS TO STAY AT WORK: A QUALITATIVE PERSPECTIVE 2019
Artificial intelligence vs human intelligence: quotient analysis on lung VQ scan for diagnosis of pulmonary embolism 2019
Automated radiosynthesis of [177Lu]Lu‐PSMA‐617 on the iPHASE MultiSyn module 2019
Correlation of metabolic parameters on 18F‐FDG PET with recurrence in patients with resected lung metastases from colorectal carcinoma 2019
Volar hand uptake on 18F‐FDG whole body PET/CT predicts glucocorticoid-responsive disease in polymyalgia rheumatica: results from the MPR-PMR study 2019
18F-FDG WHOLE BODY PET/CT AS A DIAGNOSTIC TEST FOR POLYMYALGIA RHEUMATICA IN PATIENTS WITH NORMAL INFLAMMATORY MARKERS 2018
ELEVATED THYROID STIMULATING HORMONE AS A POTENTIAL BIOMARKER FOR RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS FOLLOWING PD-1 INHIBITOR THERAPY 2018
EXTRACELLULAR VESICLES IN RHEUMATOID ARTHRITIS SYNOVIAL FLUID 2018
FIRST DOCUMENTATION OF RS3PE AFFECTING THE HANDS ON 18F-FDG WHOLE BODY PET/CT IN POLYMYALGIA RHEUMATICA 2018
FOOT ORTHOSES AND FOOTWEAR IN INDIVIDUALS WITH PATELLOFEMORAL OSTEOARTHRITIS: A PILOT RANDOMISED TRIAL 2018
Abstracts 2018
EVALUATION OF CLINICAL RISK FACTORS WHICH MAY PREDICT REGIONAL, NODAL AND METASTATIC DISEASE ON (68)GA-PSMA PET/CT 2018
HARNESSING ANALOGUES OF THE ONCRASIN-1 FOR RADIOTRACER IMAGING OF TARGETED THERAPY RESISTANCE 2018
INVESTIGATING SUITABLE VOXEL SIZE FOR PATIENTS OF VARYING BODY MASS INDEX (BMI) TO ENHANCE IMAGE QUALITY OF PET/CT IMAGES 2018
BACK PAIN ASSESSMENT CLINIC (BAC) IN PRIMARY CARE: PATIENT OUTCOMES IN THE FIRST 30 MONTHS 2017
MY KNEE IS DAMAGED AND NEEDS REPLACING: A QUALITATIVE STUDY ON PEOPLE WITH SEVERE KNEE OSTEOARTHRITIS AND THEIR PERCEPTIONS FOLLOWING A 12 WEEK WALKING PROGRAM 2017
A PHASE 1 AND BIODISTRIBUTION STUDY OF ABT-806I, AN INDIUM-111 RADIOLABELED CONJUGATE OF THE TUMOR-SPECIFIC ANTI-EGFR ANTIBODY ABT-806 2017
CORRELATION OF METABOLIC PARAMETERS ON 18F-FDG PET WITH PATHOLOGICAL RESPONSE AND OVERALL SURVIVAL IN PATIENTS WITH PANCOAST TUMOURS TREATED WITH TRIMODALITY THERAPY 2017
FDG PET/CT SCAN LENDS CLARITY IN MANAGEMENT OF PATIENT DIAGNOSIS 2017
IMAGING OF TG2 ACTIVITY IN BREAST CANCER USING RADIOLABELLED HITOMI PEPTIDES 2017
IMPLEMENTATION OF A CLINICAL REPORTING QUALITY ASSURANCE PROGRAM IN A HOSPITAL-BASED PET SERVICE 2017
MOLECULAR IMAGING OF T-CELL CO-REGULATOR FACTOR B7-H3 WITH 89Zr-DS-5573A 2017
SANDOSTATIN LAR THERAPY DIFFERENTIALLY ALTERS Ga-68-DOTATATE UPTAKE IN NORMAL TISSUES AND PRIMARY TUMOURS COMPARED TO METASTATIC LESIONS 2017
SOLID TARGET PRODUCED ISOTOPES AT AUSTIN HEALTH: 5 YEARS OF EXPERIENCE 2017
ENHANCING CONTRAST RESOLUTION OF PET/CT IMAGES TO INCREASE LESION DETECTABILITY 2017
IMPLEMENTATION OF MODULATED LOW DOSE CT FOR PET/CT SCANS TO REDUCE RADIATION DOSE TO PATIENT 2017
NIVOLUMAB INDUCED POLYMYALGIA RHEUMATICA (PMR) FINDINGS IN F-18-FDG PET/CT 2017
SENSITIVITY AND SPECIFICITY OF JOINT 18F-FDG UPTAKE ON WHOLE BODY PET/CT IN POLYMYALGIA RHEUMATICA 2017
[F-18]-DIHYDRO-TESTOSTERONE PET/CT IMAGING PROTOCOL FOR PATIENTS WITH ADVANCED PROSTATE CANCER 2017
Botox therapy in simple partial seizures - evaluated with FDG PET and MRI 2016
CROSS-DISCIPLINE CONSENSUS ON INFORMATION AND CLINICAL PRACTICES FOR MANAGEMENT OF CONTRACEPTION, PREGNANCY AND BREASTFEEDING IN RHEUMATOID ARTHRITIS 2016
High yield radiolabeling of DOTA-TATE and PSMA with (68)Ga using the new MultiSyn radiosynthesizer 2016
Investigation of novel Oncrasin-1 analogues for use in imaging kRAS mutant cancers 2016
METHOD DEVELOPMENT FOR QUALITY CONTROL AND VALIDATION OF SYNTHESIS OF 6-[18F]FLUORO-L-DOPA 2016
Synthesis and in vivo imaging of 16 beta-[18f] fluoro-5 alpha-dihydrotestosterone in castration resistant prostate cancer 2016
Synthesis of fluorine-18 agents for pet imaging of hypoxic tissue in tumours 2016
DEVELOPMENT OF A DISEASE DAMAGE INDEX IN SYSTEMIC SCLEROSIS: SURVEY OF EXPERTS AND ITEM REDUCTION USING RASCH MODELLING 2015
OPTIMIZING PHARMACOKINETICS AND TARGETING PROPERTIES OF RECOMBINANT ANTI-LEWIS Y ANTIBODY HU3S193 IN A431 TUMOR-BEARING MICE 2015
PHASE I SAFETY AND BIODISTRIBUTION STUDY OF 124I-PEG-AVP0458 DIABODY IN PATIENTS WITH TAG-72 POSITIVE OVARIAN AND PROSTATE CANCER 2015
An earlier role for PET in the investigation of PUO? A 5-year retrospective cost benefit analysis 2015
BIODISTRIBUTION OF SIRSPHERES ON 90Y-PET/CT VS. BREMSSTRAHLUNG SPECT/CT IN PATIENTS WITH LIVER CARCINOMA 2015
Barriers to health care professional adherence to clinical guidelines for the management of low back pain: a systematic review and meta-synthesis of qualitative studies. 2015
COST EFFECTIVENESS ANALYSIS OF FDG PET/CT IN ADVANCED STAGE AND RECURRENT/METASTATIC BREAST CARCINOMA 2015
F-18 RADIOLABELLING OF DBCO AS A SYNTHON FOR COPPER FREE CLICK CHEMISTRY USING THE FLEXLAB MODULE 2015
FULLY AUTOMATED PRODUCTION OF ZR-89 USING IBA NIRTA AND PINCTADA SYSTEMS 2015
L‐tyrosine confers greater residualizing properties to a d‐amino acid rich residualizing peptide for radioiodination of internalizing antibodies 2015
PROSPECTIVE STUDY OF WHOLE BODY FDG PET/CT IN PATIENTS WITH POLYMYALGIA RHEUMATICA 2015
Site-specific enzymatic and click chemistry bioconjugation of metal complexes to single-chain antibodies for PET/CT imaging of activated platelets 2015
THE EFFECT OF A THREE YEAR EXERCISE INTERVENTION ON GLYCAEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES 2015
The consensus on exercise reporting template (cert checklist): a delphi study investigating a standardised method for reporting exercise programs 2015
USE OF DIRECT INTRANODAL INJECTION OF (TC)-T-99M-RHENIUM COLLOID FOR LYMPH NODE LOCALISATION: A CASE STUDY 2015
What are patient beliefs and perceptions about exercise for non‐specific chronic low back pain? A systematic review of qualitative studies 2015
A NOVEL F-18 LABELLED ANILINO SULPHOXIDE FOR PET IMAGING OF TUMOUR HYPOXIA 2014
ADMITTING TEAM IMPACTS USE OF HEART FAILURE MEDICATIONS IN PATIENTS ADMITTED WITH HEART FAILURE EXACERBATION 2014
APPROPRIATE USE OF THE TRANSTHORACIC ECHOCARDIOGRAM 2014
ASSESSING METABOLIC AND HYPOXIC CHANGES TO TREATMENT IN COLORECTAL XENOGRAFTS WITH NANOPET/MRI 2014
C-11-CHOLINE PET IS SUPERIOR TO T2-WEIGHTED MRI FOR LOCALISING MALIGNANT INTRAPROSTATIC LESIONS FOR GUIDING PROSTATE CANCER FOCAL THERAPIES 2014
FACTORS AFFECTING DOSE OPTIMISATION IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA 2014
FUNCTIONAL IMAGING WITH (68)GA-DOTATATE PET/CT SCAN IN PATIENTS WITH NEUROENDOCRINE TUMOURS 2014
Is fosfomycin a potential treatment alternative for multidrug-resistant gram negative prostatitis? 2014
PROGNOSTICATOR SHOWDOWN: METABOLIC VS PATHOLOGICAL RESPONSE TO PREOPERATIVE CHEMOTHERAPY FOR COLORECTAL LIVER METASTASES 2014
SURVIVAL OUTCOMES FOR RADIOEMBOLISATION OF INOPERABLE LIVER MALIGNANCIES USING YTTRIUM-90 RESIN MICROSPHERES: AUSTIN HOSPITAL EXPERIENCE 2014
SYNTHESIS OF F-18 FLUOROESTRADIOL USING THE FLEXLAB SYSTEM 2014
WHOLE BODY FDG-PET/CT IMAGING IN A PREGNANT WOMAN - IS IT SAFE? 2014
REGIONAL AND SEASONAL VARIATION IN AIRBORNE GRASS POLLEN LEVELS BETWEEN CITIES OF AUSTRALIA AND NEW ZEALAND 2013
A PHASE I IMAGING AND PHARMACODYNAMIC TRIAL OF CS-1008 IN PATIENTS WITH METASTATIC COLORECTAL CANCER 2013
A PRELIMINARY REVIEW OF PET DOSE DISPENSING PRACTICES WITH EXTREMITY MEASUREMENTS 2013
AUTOMATED PRODUCTION OF 124I AND 64CU USING IBA TERIMO AND PINCTADA METAL ELECTROPLATING AND PROCESSING MODULES 2013
CORONARY ARTERY CALCIUM SCORING ON ROUTINE PET/CT 2013
FULLY AUTOMATED CLICK RADIOLABELLING AND THE SYNTHESIS AND COUPLING OF [18F]FBEM TO GLUTATHIONE USING THE IPHASE FLEXLAB MODULE 2013
Metabolic Response to Preoperative Chemotherapy Predicts Prognosis in Colorectal Liver Metastases 2013
NEMA NU2 2007 PERFORMANCE MEASUREMENTS AND COMPARISONS OF 2ND AND 3RD GENERATION GEMINI TIME-OF-FLIGHT PET/CT SCANNERS 2013
PRE-CLINICAL IMAGING DEVELOPMENTS AT THE ACRF CENTRE FOR TRANSLATIONAL CANCER RESEARCH AND IMAGING 2013
Pre‐Radiotherapy [18F]‐Fluoromisonidazole PET Is Predictive of Long Term Local Control and Survival in Head and Neck Cancer 2013
QUALITY ASSURANCE IN NUCLEAR MEDICINE AND PET 2013
SYNTHESIS AND EVALUATION OF A PEGYLATED F-18 LABELLED NITROPHENYL SULFOXIDE FOR PET IMAGING OF TUMOUR HYPOXIA 2013
A FEASIBILITY STUDY OF USING INSTADOSE PERSONAL DOSIMETERS IN A PET FACILITY 2012
A GIBBS ARTIFACT IN PET IMAGES RECONSTRUCTED WITH THE TRUEX ALGORITHM 2012
A NOVEL NITROFURAN FOR THE IMAGING OF TUMOUR HYPOXIA 2012
C-11-CHOLINE PET SCANNING IS MORE ACCURATE THAN BIOPSY IN ASSESSMENT OF LOCALIZED PROSTATE CANCER PLANNED FOR RADICAL PROSTATECTOMY 2012
DETECTION OF ACTIVATED PLATELETS IN CAROTID ARTERY THROMBOSIS IN MICE WITH RADIOLABELED SINGLE CHAIN ANTIBODIES FOR PET 2012
EFFECT OF VOXEL SIZE WHEN CALCULATING PATIENT SPECIFIC RADIONUCLIDE DOSIMETRY ESTIMATES USING DIRECT MONTE CARLO SIMULATION 2012
F-18-FDG PET IN THE MANAGEMENT OF LYMPHOMATOID GRANULOMATOSIS 2012
F-18-FDG UPTAKE IN BOWEL IN DIABETIC PATIENTS TREATED WITH METFORMIN 2012
FDG-PET/CT FINDINGS IN TOPHACEOUS GOUT 2012
HYPOXIA-TARGETED RADIOTHERAPY USING FMISO PET IMPROVES TUMOUR CONTROL IN HEAD AND NECK CANCER 2012
IMPLEMENTATION OF A SOLID TARGET FACILITY AT AUSTIN HEALTH FOR THE PRODUCTION OF CU-64 AND I-124 2012
MANAGEMENT IMPACT OF FDG PET/CT IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA: A COMPARATIVE STUDY WITH I-131 WHOLE BODY SCAN AND SERUM THYROGLOBULIN 2012
ONGOING STRATEGIES TO MANAGE RADIATION EXPOSURE TO PET STAFF DURING DOSE DISPENSING, DOSE ADMINISTRATION AND PATIENT POSITIONING 2012
THE RADIATION FINGER DOSE OF SENIOR AND JUNIOR STAFF USING AUTOMATED RADIOPHARMACEUTICAL DISPENSING 2012
TUMOUR DELINEATION FOR PROSTATE CANCER RADIOTHERAPY USING C-11-CHOLINE PET SCANS: AN IMAGING-PATHOLOGY CORRELATION STUDY 2012
WHEN IS A HIGH BLOOD GLUCOSE LEVEL TOO HIGH FOR FDG-PET BRAIN IMAGING FOR DEMENTIA? 2012
ADVERSE OUTCOMES ASSOCIATED WITH KNEE ARTHROSCOPY IN VICTORIA, AUSTRALIA FROM 2000-2009 2012
TRENDS IN THE UTILISATION OF KNEE ARTHROSCOPIES AMONG A POPULATION-BASED COHORT IN VICTORIA, AUSTRALIA 2000-2009 2012
A PILOT STUDY OF THE SAFETY, EFFICACY, AND EFFECTS ON FUNCTIONAL IMAGING OF THE COMBINATION OF cG250 AND SUNITINIB IN PATIENTS WITH ADVANCED RENAL CELL CARCINOMA (RCC) 2011
IMPLEMENTATION OF AN IN VITRO ASSAY FOR PHASE 1 METABOLISM OF PET RADIOTRACERS 2011
IMRT DOSE PAINTING FOR LOCALISED PROSTATE CARCINOMA USING C-11-CHOLINE PET SCAN 2011
MOLECULAR IMAGING OF DEATH RECEPTOR 5 (DR5) OCCUPANCY IN-VIVO BY HUMANIZED MONOCLONAL ANTIBODY CS-1008 2011
TOTAL GLYCOLYTIC VOLUME (TGV) IS A PROGNOSTIC INDICATOR IN COLORECTAL LIVER METASTASES 2011
A brain activation study of limb position sense in stroke affected individuals with and without sensory training, and in healthy aged 2006
IN_Touch: Imaging Neuroplasticity of Touch after stroke: preliminary findings of brain activation with moderate and severe touch impairment 2006
Quantitative Analysis of FDG PET/CT for Assessment of Therapy Response in Patients with Non-Small Cell Lung Carcinoma Treated with Nivolumab 2019
Should copper inserts be used for dose calibrator measurements? 2019
TITRATION OF (TECHNETIUM)-T-99M-MACROAGGREGATED ALBUMIN DOSES IN LUNG VENTILATION/PERFUSION IMAGING AND ITS EFFECT ON DOSE REDUCTION 2019
USE OF THE FLEXLAB RADIOSYNTHESISER FOR THE FULLY AUTOMATED SYNTHESIS OF 16B-[F-18]FLUORO-5A-DIHYDROTESTOSTERONE 2015
An inverse association between patellar tendinopathy and patellar cartilage defects: results from two community-based studies 2013
Obesity is a risk factor for patellar tendinopathy in middle-aged adults 2013
Risk factors for patellar tendinopathy in middle-aged women 2013
GLYOXIA: INTEGRATED ANALYSIS OF GLUCOSE METABOLISM AND HYPOXIA WITH F-18-FLUOROMISONIDAZOLE (FMISO) AND 18F-FLUORODEOXYGLUCOSE (FDG) PET IN HIGH GRADE GLIOMA PATIENTS 2012
Nuclear medicine in the era of personalised medicine. 48:497-499. 2018
Local Perspective On A Rare Brain Tumour: Adult Medulloblastoma – Author Reply 2014
Marantic endocarditis presenting with multifocal neurological symptoms 2013

has subject area

General & Internal Medicine (Science Metrix)

La Trobe University Scholars

Internal Medicine Journal Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)